JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floch, M. H.
Right arrow Articles by Groisser, V. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floch, M. H.
Right arrow Articles by Groisser, V. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 256-258, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics

THE EFFECT OF HEPARIN ON THE ARGININE (BAEE) ESTERASE ACTIVITY OF BLOOD

Martin H. Floch 1 and Victor W. Groisser 2

1 U. S. Army Tropical Research Medical Laboratory, APO 851, New York, New York
2 Gastrointestinal Research Laboratory, Seton Hall College of Medicine, and Jersey City Medical Center, Jersey City, New Jersey

Addition of heparin in small quantities to whole blood, serum, or oxalated plasma causes an increase in the rate of hydrolysis of benzoyl-1-arginine ethyl ester. Larger quantities of heparin will inhibit this esterase activity of blood.

Submitted on July 11, 1961






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.